CANNAPHARMARX, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cannapharmarx, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Cannapharmarx, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 663M shares, a 125% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 663M +368M +125% Sep 30, 2024 10-Q 2024-11-14
Q1 2024 560M +265M +89.9% Mar 31, 2024 10-Q 2024-06-25
Q4 2023 441M +167M +60.8% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 295M +37.2M +14.4% Sep 30, 2023 10-Q 2023-11-17
Q2 2023 301M +73.4M +32.3% Jun 30, 2023 10-Q 2023-10-13
Q1 2023 295M +126M +75% Mar 31, 2023 10-Q 2023-09-22
Q4 2022 274M +149M +118% Dec 31, 2022 10-Q 2023-11-17
Q3 2022 258M +162M +170% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 227M +154M +208% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 168M +119M +240% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 126M +78.5M +167% Dec 31, 2021 10-K 2023-09-01
Q3 2021 95.3M +52.7M +124% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 73.8M +31.3M +73.8% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 49.5M +12.9M +35.2% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 47M +10.5M +28.8% Dec 31, 2020 10-K 2022-04-15
Q3 2020 42.7M +6.52M +18% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 42.4M +10M +30.9% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 36.6M +4.2M +13% Mar 31, 2020 10-Q 2020-06-29
Q4 2019 36.5M +17.5M +92.6% Dec 31, 2019 10-K 2021-04-14
Q3 2019 36.1M +18.2M +101% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 32.4M +14.5M +80.6% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 32.4M +14.5M +80.6% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 18.9M +982K +5.47% Dec 31, 2018 10-K 2020-05-27
Q3 2018 18M 0 0% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 18M 0 0% Jun 30, 2018 10-Q 2018-09-14
Q1 2018 18M 0 0% Mar 31, 2018 10-Q 2018-09-14
Q4 2017 18M 0 0% Dec 31, 2017 10-K 2019-04-03
Q3 2017 18M 0 0% Sep 30, 2017 10-Q 2018-09-14
Q2 2017 18M 0 0% Jun 30, 2017 10-Q 2018-09-14
Q1 2017 18M 0 0% Mar 31, 2017 10-Q 2018-09-14
Q4 2016 18M 0 0% Dec 31, 2016 10-K 2018-09-14
Q3 2016 18M +1.12K +0.01% Sep 30, 2016 10-Q 2018-09-14
Q2 2016 18M +1.12K +0.01% Jun 30, 2016 10-Q 2018-09-14
Q1 2016 18M +283K +1.6% Mar 31, 2016 10-Q 2018-09-14
Q4 2015 18M +586K +3.38% Dec 31, 2015 10-K 2018-09-14
Q3 2015 18M +505K +2.89% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 18M +2.41M +15.5% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 17.7M +15.3M +641% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 17.4M +15M +629% Dec 31, 2014 10-K 2018-09-11
Q3 2014 17.5M +15.1M +632% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 15.5M +13.2M +552% Jun 30, 2014 10-Q 2014-09-09
Q1 2014 2.38M Mar 31, 2014 10-Q 2014-05-19
Q4 2013 2.38M 0 0% Dec 31, 2013 10-K 2015-03-31
Q3 2013 2.38M 0 0% Sep 30, 2013 10-Q 2013-10-31
Q2 2013 2.38M 0 0% Jun 30, 2013 10-Q 2013-08-09
Q4 2012 2.38M 0 0% Dec 31, 2012 10-K 2014-02-06
Q3 2012 2.38M 0 0% Sep 30, 2012 10-Q 2012-10-17
Q2 2012 2.38M 0 0% Jun 30, 2012 10-Q 2012-07-25
Q1 2012 2.38M 0 0% Mar 31, 2012 10-Q 2012-05-07
Q4 2011 2.38M 0 0% Dec 31, 2011 10-K 2013-03-28
Q3 2011 2.38M Sep 30, 2011 10-Q 2011-10-27
Q2 2011 2.38M Jun 30, 2011 10-Q 2011-07-25
Q1 2011 2.38M Mar 31, 2011 10-Q 2011-07-01
Q4 2010 2.38M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.